CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic GHRH analog currently being studied for its role in GHRH receptor binding and somatotropic axis signaling. Research interest includes pulsatile secretion pathways, receptor pharmacology, and short half-life peptide stability in controlled in-vitro and preclinical research environments. Supplied as a sterile, lyophilised research compound. This product is intended for laboratory and research purposes only — not for human or veterinary use.
CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic GHRH analog currently being studied for its role in GHRH receptor binding and somatotropic axis signaling. Research interest includes pulsatile secretion pathways, receptor pharmacology, and short half-life peptide stability in controlled in-vitro and preclinical research environments. Supplied as a sterile, lyophilised research compound. This product is intended for laboratory and research purposes only — not for human or veterinary use.
Research-grade compounds manufactured under strict quality standards with batch-tested purity and accurate dosing assurance.
Every batch verified for consistency
Strict analytical testing protocols
Controlled laboratory processes
Precision measured formulations
Reviews
There are no reviews yet.